Search Result

All Related Services Other Content

Industry Shift: FDA Goes Vegan? Approaching Drug Development With FinesseIn 2012, drug development specialists started an initiative to create predictive Oral Bioavailability Tools (OrBiTo). This initiative recognized the need to mo...
Crystallization Development Services Based on in-depth research on the properties of the crystal form itself and the transformation relationship between crystal forms, Crystal Pharmatech can offer a robust and scalable crystallization process that yields a reproducible high-quality solid form.
Excipient Selection and Compatibility Studies Excipients play an important role in drug release, drug stability and manufacture of drug product. We help customers select the appropriate excipients in early formulation development through screenin...
Analytical Chemistry We will provide our valued customers with analytical chemistry research and quality control services for NCEs throughout their life cycle from the early clinical stage to commercial manufacturing. Ana...
Development and Production Application Cases of Amorphous Solid Dispersion Formulations (II) - Spray Drying In the preceding article, we discussed the application of hot-melt extrusion technology in developing amorphous solid dispersions (ASD) for pharmaceutical formulations. The process involves dispersing...
Utilizing Compaction Simulation for Advancing Oral Dosage Formulation Design
Discovery & Development US 2025 We're heading to San Diego October 2-3 and bringing a team ready to talk First-Time-Right CMC for small molecules—from solid form to formulation and IND.Date: October 2-3Location: Sheraton San Di...
Holistic Polymorph Screening - Identify the Lead Crystal Form and Accelerate CMC Progress
About Us Crystal Pharmatech, founded in 2010, is a global contract research organization with approximately 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. We offer API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply, bioanalytical and biomarker testing, biologics CMC analytics, and clinical pharmacology.
Pre-formulation Studies Crystal Pharmatech can bridge the gap between the API and formulation through our solid-state service, which can be seamlessly progressed into pre-formulation research while de-risking your assets.
Formulations for PK/Efficacy/Tox Studies We adopt integrated approach to find the right form and formulation through our SMART services, leading to the shortest possible development timelines with limited resource utilization.
Case Study 6: Oxybutynin- Crystalline Change From Salt to Free Base Oxybutynin HCl (Fig. 14) has been recognized as a BDDCS I compound exhibiting high solubility and permeability (Benet et al. 2011). It has been used in a variety of marketed products for the treatment...
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the Drug Manufacturing ...